Iridex Welcomes Sean Teo & Michael Wu as International Sales Area Managers for Asia Pacific > IRIDEX



Mountain View, CA — September 26, 2022 — Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announces the appointment of Sean Teo and Michael Wu to the Iridex team as International Sales Area Managers for Asia Pacific.

Sean and Michael bring over 40 years of combined expertise in sales, marketing and management of lasers and medical devices for ophthalmology in the Asia Pacific region to Iridex. Michael served as sales and distribution manager for Asia at Ellex Medical, a maker of ophthalmic laser and ultrasound systems where he successfully launched many new products in the Asian market. Sean spent many years as Clinical Product Manager for the Asia Pacific region at Topcon Medical Laser Systems/ OptiMedica, where he managed product life cycle, developed product training programs, and provided distributor support for marketing and sales plans.

“It’s a pleasure welcoming both Sean and Michael to our International team. Their sales and experience in developing sales account strategies, managing clinical experience programs and selling laser products will be a great addition to Iridex.” said Bassem Bouhabib, Vice President, International Sales, Iridex.

“I am excited to be a part of this outstanding team,” said Sean. “Iridex has a strong foundation not only of innovative products, but also of clinical and service support programs. I look forward to building strong customer relationships as we grow our business.”

“I am honored to join the Iridex team,” said Michael. “Iridex is a world leader in the development and marketing of versatile laser-based medical systems, and I look forward to being part of such an extraordinary team as we continue growing glaucoma and retina laser markets in Asia Pacific region.”

“It’s great to have Sean and Michael join the Iridex team. They bring a wealth of experience in sales and marketing to the Iridex customers in the Asia Pacific marketplace,” said Dave Bruce, CEO of Iridex Corporation.

About Iridex

Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven therapy for targeted sight-threatening eye conditions. Iridex’s products treat glaucoma, diabetic macular edema, and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit

Iridex Media Contact

Jamie Hall

Posted in: News
Actions: E-mail | Permalink |